Principaux concurrents
PER (Y) Price to Book (Y) PEG (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Rendement du dividende (Y) Capi.($)
- - - - - - - 183 M
34.2x6.17x0.89x8.53x26.72x27.15x0,05 % 55,78 Md
19.78x3.77x-2.06x6x13.04x15.21x1,52 % 55,66 Md
-18.16x1.12x2.88x4.33x-7.56x-6.2x-.--% 23,84 Md
-39.15x52.52x0.67x12.94x-37.74x-40.61x-.--% 22,7 Md
22.36x2.56x-1.04x4.48x14.84x16.67x-.--% 16,12 Md
17.25x4.91x1.21x5x11.74x12.79x-.--% 13,64 Md
44.81x11.96x0.41x18.09x56.4x45.28x-.--% 14,8 Md
-75.62x27.04x1.65x7.78x-69.72x-55.85x-.--% 12,16 Md
-13.53x-92.46x9.8x103.56x-15.5x-15.02x-.--% 11,85 Md
-25.5x26.18x-0x23.32x-29.94x-24.22x-.--% 11,34 Md
-12.51x147.23x0.61x3254.69x-15.14x-12.36x-.--% 11,11 Md
-21.54x8.26x10.96x797.8x-18.72x-18.63x-.--% 9,76 Md
-10.32x - -0.08x - - - - 9,19 Md
-6.64x - -0.13x - -6.81x-6.26x-.--% 8,33 Md
-28.6x7.86x-0.52x - -25.85x-25.01x-.--% 7,83 Md
114.26x2.31x-2.01x4.59x22.77x49.7x0,13 % 7,11 Md
31.13x2.4x-1.12x5.85x17.27x28.49x - 7,56 Md
-17.23x26.57x5.09x961.28x-14.67x-14.54x-.--% 6,59 Md
-16.7x19.54x-2.96x682.42x-18.41x-15.55x-.--% 6,62 Md
Moyenne -0,09x 15,17x 1,28x 368,79x -5,40x -2,16x 0,1 % 15,61 Md
Moyenne pondérée par Capi. 5,38x 12,59x 0,83x 202,65x 1,67x 3,55x 0,3 %
Médicaments bio-thérapeutiques
🔇